Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 22805536.
- Also identified by DOI 10.1111/j.1471-0528.2012.03412.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To elaborate a nomogram based on markers of ovarian reserve for the calculation of the appropriate starting dose of follicle-stimulating hormone (FSH). Cohort study of infertile women. In vitro fertilisation (IVF) unit, University Hospital of Modena, Italy. Women aged 18-40 years (n = 346) and undergoing their first IVF cycle. Serum FSH and anti-Müllerian hormone (AMH) measurement. Development of a model for the prediction of ovarian response to FSH. A model based on age, AMH and FSH was able to accurately predict the ovarian sensitivity and accounted for 30% of the variability of ovarian response to FSH. An FSH dosage nomogram was constructed and overall it predicts a starting FSH dose <225 IU in 55.1 and 25.9% of women younger and older than 35 years, respectively. In the present study we clearly demonstrated that the daily FSH dose may be calculated on the basis of a woman's age and two markers of ovarian reserve, namely AMH and FSH, with the first two vari;s (age and AMH) being the most significant predictors. The nomogram we developed seems easily applicable for clinicians during their daily clinical practice.
Medical subject headings
- Anti-Mullerian Hormone
- Fertilization in Vitro
- Follicle Stimulating Hormone
- Infertility, Female
- Nomograms